Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
Clinical trial NCT02639091 · COMPLETED
Trial details
- NCT number
- NCT02639091
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-03
- Primary completion
- 2018-05-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.